Osaic Holdings’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.71K Sell
9,063
-2,403
-21% -$2.29K ﹤0.01% 6898
2026
Q2
$18.2K Buy
11,466
+2,398
+26% +$1.49K ﹤0.01% 6243
2026
Q1
$1.9K Buy
9,068
+95
+1% +$41 ﹤0.01% 7165
2025
Q4
$14.2K Hold
8,973
– – ﹤0.01% 6103
2025
Q3
$9.5K Hold
8,973
– – ﹤0.01% 6396
2025
Q2
$5.34K Buy
+3,340
New +$5.32K ﹤0.01% 6505
2025
Q1
– Sell
-3,384
Closed -$6.4K – 7645
2024
Q4
$6.4K Hold
3,384
– – ﹤0.01% 6053
2024
Q3
$18.1K Hold
3,384
– – ﹤0.01% 5447
2024
Q2
$25K Buy
3,384
+3,181
+1,567% +$25.5K ﹤0.01% 5183
2024
Q1
$2.42K Sell
203
-1,824
-90% -$14.7K ﹤0.01% 6399
2023
Q4
$16K Sell
2,027
-1,323
-39% -$11.2K ﹤0.01% 5603
2023
Q3
$14.8K Buy
3,350
+2,150
+179% +$47.6K ﹤0.01% 5717
2023
Q2
$41.7K Buy
1,200
+103
+9% +$2.81K ﹤0.01% 5055
2023
Q1
$23.9K Buy
1,097
+321
+41% +$7.18K ﹤0.01% 5468
2022
Q4
$16.3K Buy
776
+112
+17% +$2.44K ﹤0.01% 5699
2022
Q3
$16K Sell
664
-38
-5% -$884 ﹤0.01% 5755
2022
Q2
$14K Sell
702
-222
-24% -$6.38K ﹤0.01% 5861
2022
Q1
$33K Sell
924
-535
-37% -$16.7K ﹤0.01% 5387
2021
Q4
$40K Sell
1,459
-53
-4% -$1.89K ﹤0.01% 5308
2021
Q3
$66K Sell
1,512
-1,681
-53% -$81.1K ﹤0.01% 4892
2021
Q2
$158K Sell
3,193
-78
-2% -$3.62K ﹤0.01% 4072
2021
Q1
$147K Sell
3,271
-160
-5% -$6.13K ﹤0.01% 4027
2020
Q4
$89K Sell
3,431
-408
-11% -$8.53K ﹤0.01% 4134
2020
Q3
$55K Buy
3,839
+1,357
+55% +$30.2K ﹤0.01% 4229
2020
Q2
$64K Buy
2,482
+40
+2% +$713 ﹤0.01% 4017
2020
Q1
$30K Hold
2,442
– – ﹤0.01% 4378

Other funds holding OTLK

Osaic Holdings's OTLK Position: Q3 2026 in Review

Osaic Holdings reduced its Outlook Therapeutics (OTLK) stake by 21% in Q3 2026, selling an estimated $2.29K and leaving 9,063 shares worth $5.71K. The position accounts for ﹤0.01% of the portfolio, ranked #6898.

Osaic Holdings first reported a position in OTLK in Q1 2020 and has held it in 26 quarters since. The position peaked at $158K in Q2 2021. 82 funds tracked by Wall St. Rank hold OTLK as of Q3 2026.

  • Osaic Holdings held 9,063 shares of Outlook Therapeutics worth $5.71K as of Q3 2026.
  • Osaic Holdings sold 2,403 Outlook Therapeutics shares in Q3 2026, an estimated $2.29K.
  • Outlook Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #6898 holding.
  • Osaic Holdings first reported a position in Outlook Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Outlook Therapeutics position peaked at $158K in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.